Don Healey - 07 Jan 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Chief Technology Officer
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
07 Jan 2022
Net transactions value
$0
Form type
4
Filing time
11 Jan 2022, 15:33:53 UTC
Previous filing
05 Oct 2021
Next filing
01 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACET Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 07 Jan 2022 Common Stock 125,000 $15.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the Grant Date, provided that the Reporting Person maintains a service relationship with the Company as of the applicable vesting dates.